Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2009 1
2010 2
2011 1
2012 1
2014 2
2015 4
2016 5
2017 6
2018 6
2019 4
2020 5
2021 3
2022 4
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial.
Laffel LM, Danne T, Klingensmith GJ, Tamborlane WV, Willi S, Zeitler P, Neubacher D, Marquard J; DINAMO Study Group. Laffel LM, et al. Lancet Diabetes Endocrinol. 2023 Mar;11(3):169-181. doi: 10.1016/S2213-8587(22)00387-4. Epub 2023 Feb 1. Lancet Diabetes Endocrinol. 2023. PMID: 36738751 Free PMC article. Clinical Trial.
Congenital Hypothyroidism: Screening and Management.
Rose SR, Wassner AJ, Wintergerst KA, Yayah-Jones NH, Hopkin RJ, Chuang J, Smith JR, Abell K, LaFranchi SH; SECTION ON ENDOCRINOLOGY EXECUTIVE COMMITTEE; COUNCIL ON GENETICS EXECUTIVE COMMITTEE. Rose SR, et al. Among authors: wintergerst ka. Pediatrics. 2023 Jan 1;151(1):e2022060419. doi: 10.1542/peds.2022-060419. Pediatrics. 2023. PMID: 36827523
Congenital Hypothyroidism: Screening and Management.
Rose SR, Wassner AJ, Wintergerst KA, Yayah-Jones NH, Hopkin RJ, Chuang J, Smith JR, Abell K, LaFranchi SH; SECTION ON ENDOCRINOLOGY EXECUTIVE COMMITTEE; COUNCIL ON GENETICS EXECUTIVE COMMITTEE. Rose SR, et al. Among authors: wintergerst ka. Pediatrics. 2023 Jan 1;151(1):e2022060420. doi: 10.1542/peds.2022-060420. Pediatrics. 2023. PMID: 36827521
Turner Syndrome and Klinefelter Syndrome.
Kingery SE, Wintergerst KA. Kingery SE, et al. Among authors: wintergerst ka. Adolesc Med State Art Rev. 2015 Aug;26(2):411-27. Adolesc Med State Art Rev. 2015. PMID: 26999880 Review. No abstract available.
Nrf2: Redox and Metabolic Regulator of Stem Cell State and Function.
Dai X, Yan X, Wintergerst KA, Cai L, Keller BB, Tan Y. Dai X, et al. Among authors: wintergerst ka. Trends Mol Med. 2020 Feb;26(2):185-200. doi: 10.1016/j.molmed.2019.09.007. Epub 2019 Nov 1. Trends Mol Med. 2020. PMID: 31679988 Free article. Review.
Depression and Anxiety Screening in Adolescents With Diabetes.
Watson SE, Spurling SE, Fieldhouse AM, Montgomery VL, Wintergerst KA. Watson SE, et al. Among authors: wintergerst ka. Clin Pediatr (Phila). 2020 May;59(4-5):445-449. doi: 10.1177/0009922820905861. Epub 2020 Feb 17. Clin Pediatr (Phila). 2020. PMID: 32066264
Nrf2 transcriptional upregulation of IDH2 to tune mitochondrial dynamics and rescue angiogenic function of diabetic EPCs.
Dai X, Wang K, Fan J, Liu H, Fan X, Lin Q, Chen Y, Chen H, Li Y, Liu H, Chen O, Chen J, Li X, Ren D, Li J, Conklin DJ, Wintergerst KA, Li Y, Cai L, Deng Z, Yan X, Tan Y. Dai X, et al. Among authors: wintergerst ka. Redox Biol. 2022 Oct;56:102449. doi: 10.1016/j.redox.2022.102449. Epub 2022 Aug 28. Redox Biol. 2022. PMID: 36063728 Free PMC article.
46 results